Bnp Paribas Asset Management Holding S.A. Vera Therapeutics, Inc. Transaction History
Bnp Paribas Asset Management Holding S.A.
- $41 Billion
- Q2 2025
A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 416 shares of VERA stock, worth $12,579. This represents 0.0% of its overall portfolio holdings.
Number of Shares
416Holding current value
$12,579% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VERA
# of Institutions
201Shares Held
65.2MCall Options Held
1.58MPut Options Held
358K-
Avoro Capital Advisors LLC New York, NY6.3MShares$191 Million2.71% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.48MShares$135 Million0.01% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.43MShares$104 Million9.64% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.35MShares$101 Million1.81% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$101 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $818M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...